# Marnie McCoy

> Marnie McCoy is a startup investor at BioAdvance (Wayne). See 0 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: Angel Investor
- Fund: [BioAdvance](https://shizune.co/investors/profile/bioadvance)
- Location: Wayne, United States
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/marnie-mccoy-02b94413

Marnie McCoy is a startup investor at BioAdvance in Wayne. As program director at BioAdvance, Ms. McCoy is responsible for the maintaining the organization’s outreach to applicants and for internal facilitation of the funding application and review process. Ms. McCoy is also responsible for a variety of research and analysis initiatives at BioAdvance -- organizing and maintaining a variety of internaldatabases focused on quantifying regional growth, summarizing BioAdvance portfolio company progress, organizing data related to venture capital metrics. She also prepares final funding agreements for portfolio companies. Previously Ms. McCoy worked with QED in Malvern, PA as research and information manager. QED provides advice and counsel to life sciences companies and organizations.Ms. McCoy holds a BA in psychology from Millersville University and completed MA coursework in counseling at Trinity International University.

## Contacts

5 contacts available for Marnie McCoy: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/marnie-mccoy?utm_source=investor_profile

## About BioAdvance

VC Fund · Philadelphia, United States

BioAdvance provides funding to startup life sciences companies in Southeastern Pennsylvania through its new $50 million Greenhouse Fund. They invest in therapeutics, devices, diagnostics and platform technologies focused on human health.Since its first investments in 2003, BioAdvance has become one of the nation's leading investorsproviding pre-seed and seed-stage funding. To date they have committed more than $40 million to more than 50 seed-stage companies and 17 pre-seed companies. Their portfolio companies are working to develop products to treat health problems including Alzheimer's disease, cancer, obesity, GI disorders, neurological and respiratory illnesses. BioAdvance was established with $33 million from the Commonwealth of Pennsylvania's share of tobacco settlement monies.

5 contacts available at BioAdvance.

| Name | Title | Profile |
| --- | --- | --- |
| Shahram Hejazi | Partner | https://shizune.co/investors/profile/shahram-hejazi |
| Frederick Jones | Partner | https://shizune.co/investors/profile/frederick-jones |
| Gregory Harriman | Partner and Chief Investment Officer | https://shizune.co/investors/profile/gregory-harriman |
| Jeff Edelson | Entrepreneur in Residence / Scientific Liason | https://shizune.co/investors/profile/jeff-edelson |
| Marnie McCoy | Program Director | https://shizune.co/investors/profile/marnie-mccoy |

## FAQ

### How do I contact Marnie McCoy?

Public channels for Marnie McCoy include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co